应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
02359 药明康德
已收盘 04-30 16:08:17
60.150
-0.500
-0.82%
最高
62.550
最低
59.850
成交量
767.03万
今开
62.550
昨收
60.650
日振幅
4.45%
总市值
1,737亿
流通市值
232.78亿
总股本
28.88亿
成交额
4.64亿
换手率
1.98%
流通股本
3.87亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
4月30日药明康德发生2笔大宗交易 成交金额920.17万元
证券之星 · 17:57
4月30日药明康德发生2笔大宗交易 成交金额920.17万元
药明康德04月30日主力净流出2825.5万元 散户资金买入
市场透视 · 16:15
药明康德04月30日主力净流出2825.5万元 散户资金买入
高盛：升药明康德(02359)目标价至74.9港元 评级“中性”
智通财经网 · 15:44
高盛：升药明康德(02359)目标价至74.9港元 评级“中性”
药明康德：高盛上调目标价，业绩强劲
和讯网 · 13:03
药明康德：高盛上调目标价，业绩强劲
高盛：上调药明康德目标价至74.9港元上调2025至27年纯利预测
动脉网 · 12:49
高盛：上调药明康德目标价至74.9港元上调2025至27年纯利预测
【大行评级丨高盛：上调药明康德目标价至74.9港元 上调2025至27年纯利预测】高盛发表研究报告指，药明康德今年首季业绩强劲，管理层维持其2025财年指引，符合该行预期，认为如果未来1至2个季度持续强势，公司有空间在下半年提高指引。该行料公司的TIDES业务会在今年增长65%(官方指引增长60%)，将2025年至2027年各年的TIDES收入预测分别提高3.1%、5%及5%。该行上调对公司2025年至2027年各年纯利预测分别7%、3.5%及2.3%，以反映TIDES业务好过预期和小分子研发及制造的交付，将H股目标价由70.9港元升至74.9港元，维持“中性”评级。
金融界 · 12:41
【大行评级丨高盛：上调药明康德目标价至74.9港元 上调2025至27年纯利预测】高盛发表研究报告指，药明康德今年首季业绩强劲，管理层维持其2025财年指引，符合该行预期，认为如果未来1至2个季度持续强势，公司有空间在下半年提高指引。该行料公司的TIDES业务会在今年增长65%(官方指引增长60%)，将2025年至2027年各年的TIDES收入预测分别提高3.1%、5%及5%。该行上调对公司2025年至2027年各年纯利预测分别7%、3.5%及2.3%，以反映TIDES业务好过预期和小分子研发及制造的交付，将H股目标价由70.9港元升至74.9港元，维持“中性”评级。
高盛：上调药明康德目标价至74.9港元 上调2025至27年纯利预测
美港电讯 · 12:41
高盛：上调药明康德目标价至74.9港元 上调2025至27年纯利预测
实质性进展！药明康德股东大会通过重磅股东回报计划
证券市场周刊 · 10:58
实质性进展！药明康德股东大会通过重磅股东回报计划
港股开盘，恒指开涨0.14%，科指开涨0.21%。药明康德(02359.HK)涨超3%，招商银行(03968.HK)绩后
美港电讯 · 09:20
港股开盘，恒指开涨0.14%，科指开涨0.21%。药明康德(02359.HK)涨超3%，招商银行(03968.HK)绩后
【4月29日两融净卖出前十：胜宏科技（-1.81亿元）、药明康德（-1.61亿元）】沪深两市数据显示，4月29日，融资净卖出前十的股票分别为：胜宏科技（-1.81亿元）、药明康德（-1.61亿元）、江苏银行（-1.19亿元）、南京银行（-7983.85万元）、中航产融（-6721.00万元）、华西能源（-6568.39万元）、振华科技（-6564.27万元）、道通科技（-5941.68万元）、紫光国微（-5557.17万元）、龙溪股份（-5524.74万元）。
金融界 · 09:07
【4月29日两融净卖出前十：胜宏科技（-1.81亿元）、药明康德（-1.61亿元）】沪深两市数据显示，4月29日，融资净卖出前十的股票分别为：胜宏科技（-1.81亿元）、药明康德（-1.61亿元）、江苏银行（-1.19亿元）、南京银行（-7983.85万元）、中航产融（-6721.00万元）、华西能源（-6568.39万元）、振华科技（-6564.27万元）、道通科技（-5941.68万元）、紫光国微（-5557.17万元）、龙溪股份（-5524.74万元）。
药明康德将于6月5日派发特别股息每10股3.7677港元
新浪港股 · 08:18
药明康德将于6月5日派发特别股息每10股3.7677港元
药明康德（603259）2025年一季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 06:23
药明康德（603259）2025年一季报简析：营收净利润同比双双增长，盈利能力上升
药明康德(02359)将于6月5日派发特别股息每10股3.7677港元
智通财经 · 04-29 22:30
药明康德(02359)将于6月5日派发特别股息每10股3.7677港元
药明康德(02359)4月29日斥资2000.63万元回购32.94万股A股
智通财经 · 04-29 18:29
药明康德(02359)4月29日斥资2000.63万元回购32.94万股A股
港股收盘(04.29) | 恒指收涨0.16%险守两万二 消费股多数走高 药明康德(02359)绩后涨超4%
智通财经 · 04-29 16:46
港股收盘(04.29) | 恒指收涨0.16%险守两万二 消费股多数走高 药明康德(02359)绩后涨超4%
港股收评：恒生指数涨0.16% 恒生科技指数涨0.62%
美港电讯 · 04-29 16:17
港股收评：恒生指数涨0.16% 恒生科技指数涨0.62%
智通AH统计|4月29日
智通财经 · 04-29 16:15
智通AH统计|4月29日
花旗：药明康德(02359)首季业绩超预期 予“买入”评级
智通财经 · 04-29 15:58
花旗：药明康德(02359)首季业绩超预期 予“买入”评级
野村：维持药明康德“买入”评级 目标价84.59港元
新浪港股 · 04-29 15:57
野村：维持药明康德“买入”评级 目标价84.59港元
小摩：药明康德(02359)首季业绩胜预期 料可达全年指引 目标价89港元
智通财经 · 04-29 15:44
小摩：药明康德(02359)首季业绩胜预期 料可达全年指引 目标价89港元
加载更多
公司概况
公司名称：
药明康德
所属市场：
SEHK
上市日期：
--
主营业务：
无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。
发行价格：
--
{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":60.15,"timestamp":1746000497033,"preClose":60.65,"halted":0,"volume":7670292,"delay":0,"floatShares":387000000,"shares":2888000000,"eps":2.9242841405206708,"marketStatus":"已收盘","change":-0.5,"latestTime":"04-30 16:08:17","open":62.55,"high":62.55,"low":59.85,"amount":464102544,"amplitude":0.044518,"askPrice":60.15,"askSize":39300,"bidPrice":60.1,"bidSize":10200,"shortable":3,"etf":0,"ttmEps":3.4562725078054117,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746149400000},"marketStatusCode":5,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":60.65,"dividendRate":0.017379,"openAndCloseTimeList":[[1745976600000,1745985600000],[1745989200000,1746000000000]],"volumeRatio":0.76796,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":59.17,"timestamp":1745996400000,"preClose":60.45,"halted":0,"volume":43039500,"delay":0,"premium":"-4.64"}},"requestUrl":"/m/hq/s/02359","defaultTab":"news","newsList":[{"id":"2531808938","title":"4月30日药明康德发生2笔大宗交易 成交金额920.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531808938","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531808938?lang=zh_cn&edition=full","pubTime":"2025-04-30 17:57","pubTimestamp":1746007075,"startTime":"0","endTime":"0","summary":"证券之星消息，4月30日药明康德发生大宗交易，交易数据如下：近三个月该股共发生4笔大宗交易，合计成交2165.0手，溢价成交2笔。该股近期无解禁股上市。截至2025年4月30日收盘，药明康德(603259)报收于59.17元，下跌2.12%，换手率1.72%，成交量43.04万手，成交额25.61亿元。该股最近90天内共有24家机构给出评级，买入评级23家，增持评级1家；过去90天内机构目标均价为94.4。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000036983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","02359","LU2495084118.USD","LU2242644610.SGD","LU0320764599.SGD","BK0216","LU1997245177.USD","LU2125910500.SGD","LU2045819591.USD","LU0456842615.SGD","LU1046422090.SGD","BK1141","LU1997245094.SGD","LU0052750758.USD","LU0708995583.HKD","LU1997244956.HKD","BK1583","BK1576","603259"],"gpt_icon":0},{"id":"2531085455","title":"药明康德04月30日主力净流出2825.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531085455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531085455?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:15","pubTimestamp":1746000947,"startTime":"0","endTime":"0","summary":"04月30日, 药明康德股价跌0.82%，报收60.15元，成交金额4.6亿元，换手率1.98%，振幅4.45%，量比0.77。药明康德今日主力资金净流出2825.5万元，上一交易日主力净流入6330.4万元。该股近5个交易日上涨3.22%，主力资金累计净流入7019.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入4.4亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171248a46d7629&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430171248a46d7629&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1141","BK1576","LU0052750758.USD","LU2045819591.USD","LU2242644610.SGD","LU2125910500.SGD","LU0708995583.HKD","LU0320764599.SGD","02359","LU1046422090.SGD"],"gpt_icon":0},{"id":"2531048977","title":"高盛：升药明康德(02359)目标价至74.9港元 评级“中性”","url":"https://stock-news.laohu8.com/highlight/detail?id=2531048977","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531048977?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:44","pubTimestamp":1745999089,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，高盛发布研报称，药明康德今年首季业绩强劲，管理层维持其2025财年指引，符合该行预期，认为如果未来1至2个季度持续强势，公司有空间在下半年提高指引。该行料公司的TIDES业务会在今年增长65%，将2025年至2027年各年的TIDES收入预测分别提高3.1%、5%及5%。该行上调对公司2025年至2027年各年纯利预测分别7%、3.5%及2.3%，以反映TIDES业务好过预期和小分子研发及制造的交付，将H股目标价由70.9港元升至74.9港元，维持评级“中性”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02359","603259"],"gpt_icon":0},{"id":"2531971779","title":"药明康德：高盛上调目标价，业绩强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2531971779","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531971779?lang=zh_cn&edition=full","pubTime":"2025-04-30 13:03","pubTimestamp":1745989425,"startTime":"0","endTime":"0","summary":"【4 月 30 日，高盛发布研究报告称药明康德今年首季业绩强劲】高盛指出，药明康德管理层维持其 2025 财年指引，符合预期，若未来 1 至 2 个季度持续强势，公司下半年或提高指引。该行预计公司的 TIDES 业务今年增长 65%，上调 2025 年至 2027 年各年的 TIDES 收入预测。高盛还上调对公司 2025 年至 2027 年各年纯利预测，并将 H 股目标价由 70.9 港元升至 74.9 港元，维持“中性”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430134358974b1efb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430134358974b1efb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","603259"],"gpt_icon":0},{"id":"2531245778","title":"高盛：上调药明康德目标价至74.9港元上调2025至27年纯利预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2531245778","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531245778?lang=zh_cn&edition=full","pubTime":"2025-04-30 12:49","pubTimestamp":1745988540,"startTime":"0","endTime":"0","summary":"高盛上调药明康德2025至2027年纯利预测及目标价至74.9港元，看好其TIDES业务增长及小分子研发制造交付。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043012512194e8761b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043012512194e8761b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359"],"gpt_icon":0},{"id":"2531720905","title":"【大行评级丨高盛：上调药明康德目标价至74.9港元 上调2025至27年纯利预测】高盛发表研究报告指，药明康德今年首季业绩强劲，管理层维持其2025财年指引，符合该行预期，认为如果未来1至2个季度持续强势，公司有空间在下半年提高指引。该行料公司的TIDES业务会在今年增长65%(官方指引增长60%)，将2025年至2027年各年的TIDES收入预测分别提高3.1%、5%及5%。该行上调对公司2025年至2027年各年纯利预测分别7%、3.5%及2.3%，以反映TIDES业务好过预期和小分子研发及制造的交付，将H股目标价由70.9港元升至74.9港元，维持“中性”评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531720905","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531720905?lang=zh_cn&edition=full","pubTime":"2025-04-30 12:41","pubTimestamp":1745988081,"startTime":"0","endTime":"0","summary":"高盛发表研究报告指，药明康德今年首季业绩强劲，管理层维持其2025财年指引，符合该行预期，认为如果未来1至2个季度持续强势，公司有空间在下半年提高指引。该行料公司的TIDES业务会在今年增长65%(官方指引增长60%)，将2025年至2027年各年的TIDES收入预测分别提高3.1%、5%及5%。该行上调对公司2025年至2027年各年纯利预测分别7%、3.5%及2.3%，以反映TIDES业务好过预期和小分子研发及制造的交付，将H股目标价由70.9港元升至74.9港元，维持“中性”评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30124150035619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02359","603259"],"gpt_icon":0},{"id":"2531507720","title":"高盛：上调药明康德目标价至74.9港元 上调2025至27年纯利预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2531507720","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531507720?lang=zh_cn&edition=full","pubTime":"2025-04-30 12:41","pubTimestamp":1745988074,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1046422090.SGD","LU1997245177.USD","BK1141","LU1997245094.SGD","LU0048573561.USD","LU2488822045.USD","LU1791807156.HKD","LU2237443622.USD","LU2237443895.HKD","BK0216","LU2242644610.SGD","LU2750360997.AUD","LU1868836914.USD","02359","LU0096364046.USD","LU1868837136.USD","LU2237438978.USD","LU2045819591.USD","BK4585","LU0061475181.USD","LU2471134952.CNY","BK1583","IE0034235188.USD","LU1868837300.USD","BK4127","LU1668664300.SGD","IE00BSNM7G36.USD","LU0320764599.SGD","LU0106831901.USD","IE00B19Z3B42.SGD","BK4516","IE00B19Z3581.USD","LU0742534661.SGD","LU2237443465.HKD","LU2471134879.HKD","LU0251142724.SGD","LU1997244956.HKD","LU0708995583.HKD","LU0251131958.USD","LU2237443978.SGD","LU1868836757.USD","IE0004086264.USD","LU2237443382.USD","BK4552","BK4533","BK1576","BK4550","LU2471134523.USD","603259","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2531172646","title":"实质性进展！药明康德股东大会通过重磅股东回报计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2531172646","media":"证券市场周刊","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531172646?lang=zh_cn&edition=full","pubTime":"2025-04-30 10:58","pubTimestamp":1745981887,"startTime":"0","endTime":"0","summary":"2025年4月29日，药明康德发布股东大会决议公告，公司股东大会顺利通过了分红及回购方案。同时，药明康德计划在2025年增加中期分红安排。事实上，药明康德对股东的慷慨回馈并非首次。若将当年已完成的30亿元A股回购注销纳入考量，药明康德全年累计向股东输送价值超过58亿元，相当于将年度利润的60%以上转化为股东回报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043010581194e855ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043010581194e855ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU2125910500.SGD","02359","BK1583","LU2045819591.USD","LU1046422090.SGD","BK1576","603259","LU0052750758.USD","LU0708995583.HKD","LU2242644610.SGD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2531741197","title":"港股开盘，恒指开涨0.14%，科指开涨0.21%。药明康德(02359.HK)涨超3%，招商银行(03968.HK)绩后","url":"https://stock-news.laohu8.com/highlight/detail?id=2531741197","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531741197?lang=zh_cn&edition=full","pubTime":"2025-04-30 09:20","pubTimestamp":1745976041,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0188","LU1781817850.SGD","LU2045819591.USD","LU2097828714.EUR","LU0455707207.USD","02833","LU0348735423.USD","LU1023057109.AUD","IE00BZ08YS42.EUR","MCHmain","LU0634319403.HKD","HSCEI","LU0348788117.USD","LU1048596156.SGD","LU0048580855.USD","LU1580142542.USD","HSImain","LU0708995153.HKD","513600","LU0456827905.SGD","LU0417516902.SGD","LU1969619763.USD","LU1282649141.HKD","LU0823426480.USD","LU0640798160.USD","MHImain","LU1224709979.USD","LU0314109678.HKD","LU0880133367.SGD","LU1046422090.SGD","LU1997244956.HKD","600036","LU1719994722.HKD","LU0821914370.USD","YANG","07226","IE0031814852.USD","603259","HSI","LU0011963245.USD","LU0588546209.SGD","03968","03143","02359","LU0797268264.HKD","BK0012","HHImain","IE00B031J352.USD","HSTECH","LU1152091754.HKD"],"gpt_icon":0},{"id":"2531749276","title":"【4月29日两融净卖出前十：胜宏科技（-1.81亿元）、药明康德（-1.61亿元）】沪深两市数据显示，4月29日，融资净卖出前十的股票分别为：胜宏科技（-1.81亿元）、药明康德（-1.61亿元）、江苏银行（-1.19亿元）、南京银行（-7983.85万元）、中航产融（-6721.00万元）、华西能源（-6568.39万元）、振华科技（-6564.27万元）、道通科技（-5941.68万元）、紫光国微（-5557.17万元）、龙溪股份（-5524.74万元）。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531749276","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531749276?lang=zh_cn&edition=full","pubTime":"2025-04-30 09:07","pubTimestamp":1745975255,"startTime":"0","endTime":"0","summary":"沪深两市数据显示，4月29日，融资净卖出前十的股票分别为：胜宏科技（-1.81亿元）、药明康德（-1.61亿元）、江苏银行（-1.19亿元）、南京银行（-7983.85万元）、中航产融（-6721.00万元）、华西能源（-6568.39万元）、振华科技（-6564.27万元）、道通科技（-5941.68万元）、紫光国微（-5557.17万元）、龙溪股份（-5524.74万元）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30090750029388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","02359","SGXZ90724238.SGD","BK0259","BK0038","SG9999001051.SGD","000733","SGXZ81163826.USD","BK0018","600705","BK0131","600592","LU0708995583.HKD","LU1979443071.USD","002049","LU2125910500.SGD","688208","601009","LU1997245177.USD","LU2488822045.USD","LU1997245094.SGD","603259","002630","BK1576","BK0278","BK1583","SG9999002950.SGD","SGXZ49509284.SGD","BK0197","LU1997244956.HKD","BK0062","BK0010","BK0102","600919","LU2242644610.SGD","BK0052","399300","300476","SG9999001226.SGD","BK0012","BK0068","LU0456842615.SGD","LU1934453819.USD","159982","BK0216","LU2495084118.USD","BK0188","BK0201","BK0214","LU2045819591.USD"],"gpt_icon":0},{"id":"2531743293","title":"药明康德将于6月5日派发特别股息每10股3.7677港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531743293","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531743293?lang=zh_cn&edition=full","pubTime":"2025-04-30 08:18","pubTimestamp":1745972280,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 药明康德（02359）发布公告，将于2025年6月5日派发特别股息每10股3.7677港元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-30/doc-ineuwyza0293429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1997244956.HKD","02359","LU2045819591.USD","BK1576","LU1997245177.USD","LU0708995583.HKD","LU0052750758.USD","LU0320764599.SGD","603259","BK0216","LU1046422090.SGD","LU2125910500.SGD","LU2495084118.USD","LU0456842615.SGD","LU2242644610.SGD","BK1583","LU1997245094.SGD","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2531198067","title":"药明康德（603259）2025年一季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2531198067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531198067?lang=zh_cn&edition=full","pubTime":"2025-04-30 06:23","pubTimestamp":1745965391,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期药明康德发布2025年一季报。截至本报告期末，公司营业总收入96.55亿元，同比上升20.96%，归母净利润36.72亿元，同比上升89.06%。本报告期药明康德盈利能力上升，毛利率同比增幅10.83%，净利率同比增幅56.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000006705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02359","603259"],"gpt_icon":0},{"id":"2531068756","title":"药明康德(02359)将于6月5日派发特别股息每10股3.7677港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531068756","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531068756?lang=zh_cn&edition=full","pubTime":"2025-04-29 22:30","pubTimestamp":1745937006,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)发布公告，将于2025年6月5日派发特别股息每10股3.7677港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1997245177.USD","BK1576","LU1997245094.SGD","02359","603259","LU2242644610.SGD","LU2045819591.USD","LU0708995583.HKD","BK1583","LU0320764599.SGD","LU0052750758.USD","LU0456842615.SGD","LU1997244956.HKD","BK0216","LU1046422090.SGD","LU2125910500.SGD","LU2495084118.USD","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2531876788","title":"药明康德(02359)4月29日斥资2000.63万元回购32.94万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531876788","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531876788?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:29","pubTimestamp":1745922557,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)发布公告，该公司于2025年4月29日斥资2000.63万元人民币回购32.94万股A股，每股回购价格为59.7-61.54元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399300","LU0320764599.SGD","BK1141","LU2488822045.USD","LU1997245177.USD","LU0052750758.USD","LU1997244956.HKD","LU2495084118.USD","LU2242644610.SGD","LU1997245094.SGD","BK0216","LU2045819591.USD","603259","LU0456842615.SGD","159982","LU1046422090.SGD","LU0708995583.HKD","BK1576","02359","LU2125910500.SGD","BK1583"],"gpt_icon":0},{"id":"2531272503","title":"港股收盘(04.29) | 恒指收涨0.16%险守两万二 消费股多数走高 药明康德(02359)绩后涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531272503","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531272503?lang=zh_cn&edition=full","pubTime":"2025-04-29 16:46","pubTimestamp":1745916368,"startTime":"0","endTime":"0","summary":"蓝筹股表现药明康德绩后走高。截至收盘，涨4.21%，报60.65港元，成交额7.93亿港元，贡献恒指1.39点。截至下午4点半左右，沪上阿姨孖展额已增至 102.98亿元，孖展倍数达377.51倍。截至收盘，跌4.07%，报54.25港元。青岛啤酒股份公布2025年第一季度业绩，营业收入约104.455亿元，同比增长2.91%；归属于上市公司股东的净利润约17.1亿元，同比增长7.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287335.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1997245177.USD","02359","LU0052750758.USD","LU0708995583.HKD","BK0216","LU2045819591.USD","LU0348767384.USD","HHImain","HSTECH","BK1141","02833","603259","BK1576","HSCEI","LU0456842615.SGD","LU1997245094.SGD","BK4614","YANG","09863","BK1233","BK1147","LU2495084118.USD","BK1587","LU2488822045.USD","MCHmain","BK1119","LU2242644610.SGD","LU1046422090.SGD","BK1109","BK1207","HSI","LU0348766576.USD","BK1616","513600","01318","BK1583","LU2125910500.SGD","LU1997244956.HKD","02150","LU0320764599.SGD"],"gpt_icon":1},{"id":"2531273706","title":"港股收评：恒生指数涨0.16% 恒生科技指数涨0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531273706","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531273706?lang=zh_cn&edition=full","pubTime":"2025-04-29 16:17","pubTimestamp":1745914647,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002594","BK1501","HSCEI","159938","LNNGY","LU1997245177.USD","LU0516423174.USD","03086","01011","HSImain","HSI","HYDD.SI","02833","02331","81211","YANG","09901","XPEV","LU1997245094.SGD","MHImain","HSHD.SI","BK1109","HSBA.UK","09660","82331","HHImain","02359","IE0034235303.USD","01211","BK4543","513600","603259","07226","TSYW.SI","09939","TSLL","HSTECH","TTTN","03143","EVS.SI","HSBC","MCHmain","00005","159813","TSLA","09868","BYDDY","02150","EDU","00241"],"gpt_icon":0},{"id":"2531273704","title":"智通AH统计|4月29日","url":"https://stock-news.laohu8.com/highlight/detail?id=2531273704","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531273704?lang=zh_cn&edition=full","pubTime":"2025-04-29 16:15","pubTimestamp":1745914506,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止4月29日收盘，东北电气、安德利果汁、弘业期货分列AH溢价率前三位，溢价率分别为958.82%、336.85%、320.09%；招商银行、比亚迪股份、药明康德分列AH溢价率末三位，溢价率分别为13.06%、15.59%、19.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02338","03678","00323","00347","03606","399300","IE0031814852.USD","002594","159982","81211","BK1205","01330","03968","02208","02218","02359","BYDDY","LU1813983027.USD","00670","00338","01787","01057","IE00BMCWC346.EUR","02238","01033","03143","LU0516422440.USD","02866","00300","LU1303224171.USD","00568","00956","06869","BK1540","00553","00719","01988","HYDD.SI","01658","01211","LU0640798160.USD","01877","00042","01349","02899","IE0008368742.USD","01812","01108"],"gpt_icon":1},{"id":"2531027338","title":"花旗：药明康德(02359)首季业绩超预期 予“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2531027338","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531027338?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:58","pubTimestamp":1745913487,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，花旗发布研报称，药明康德今年第一季收入达97亿元人民币，同比增长21%，持续营运业务同比增长23%;净利润37亿元人民币，同比增长89%，剔除一次性项目后增长14.5%。药明康德的TIDES业务增长非常强劲，今年第一季持续营运业务的订单积压同比增长47%，与2024年全年的47%增长相比，保持快速增长。该行予其“买入”评级，目标价92港元。该行提及，药明康德业绩表现强劲，收入及净利润分别超出该行预估4%和10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603259","02359"],"gpt_icon":0},{"id":"2531278986","title":"野村：维持药明康德“买入”评级 目标价84.59港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531278986","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531278986?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:57","pubTimestamp":1745913420,"startTime":"0","endTime":"0","summary":" 野村发布研报称，维持药明康德目标价84.59港元以及“买入”评级。2025年第一季度，药明康德收入和盈利增长均重回“两位数”水平；订单积压同比增47%。 药明康德第一季收入同比增21%至965亿元人民币（下同），尽管2024年第一季基数不高，但野村认为这一业绩还是乐观的。也要归功于化学业务的强劲表现，其分部毛利率从2024年第一季的43.3%升至47.5%，野村将其归因于规模经济。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-04-29/doc-ineuvnxv5644173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02359","603259"],"gpt_icon":0},{"id":"2531278542","title":"小摩：药明康德(02359)首季业绩胜预期 料可达全年指引 目标价89港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531278542","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531278542?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:44","pubTimestamp":1745912655,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根大通发布研报称，药明康德首季收入同比升21%，胜预期，主要是因为TIDES业务的增长强劲。该行对公司H股目标价是89港元，评级“增持”。该行亦提到，公司测试业务持续面对挑战，首季业绩同比跌5%，非通用会计准则经调整毛利率由去年的33.3%跌至23.4%。同时，生物学业务收入同比升8%，但价格战对非通用会计准则毛利率形成压力，较去年同期跌220个基点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603259","02359"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":0.1068},{"period":"1month","weight":-0.1273},{"period":"3month","weight":0.0987},{"period":"6month","weight":0.1731},{"period":"1year","weight":0.7266},{"period":"ytd","weight":0.0735}],"compareEarnings":[{"period":"1week","weight":0.0207},{"period":"1month","weight":-0.0606},{"period":"3month","weight":0.0882},{"period":"6month","weight":0.0832},{"period":"1year","weight":0.2401},{"period":"ytd","weight":0.0971}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.012449},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.006622},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.010463},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.014032},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.029314},{"month":6,"riseRate":0.666667,"avgChangeRate":0.065452},{"month":7,"riseRate":0.666667,"avgChangeRate":0.058311},{"month":8,"riseRate":0.5,"avgChangeRate":0.045883},{"month":9,"riseRate":0.5,"avgChangeRate":0.085442},{"month":10,"riseRate":0.5,"avgChangeRate":0.011462},{"month":11,"riseRate":0.333333,"avgChangeRate":0.007928},{"month":12,"riseRate":0.666667,"avgChangeRate":0.048731}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}